; and (E) other appropriate health or professional education organizations or institutions. (b) Expansion of prescribing authority The Secretary, acting through the Administrator of the Health Resources and Services Administration, shall award grants to States for the purpose of evaluating the prospect of the health professions board of such States reviewing and expanding prescribing authorities of providers, such as advance practice nurses and physician's assistants, with respect to prescribing drugs for the treatment of the abuse of prescription drugs, heroin, or other controlled substances. . 4. Prescription drug abuse training and screening programs (a) Continuing education grants The Secretary shall award grants to States to develop continuing education criteria and review processes that allow State health profession boards or State agencies to certify appropriate education and training for informed and safe prescribing of opioids and other drugs listed on schedule II or III under section 202 of the Controlled Substances Act ( 21 U.S.C. 812 ). (b) Screening program The Attorney General shall request that a practitioner registered under section 303(f) of the Controlled Substances Act ( 21 U.S.C. 823(f) ) conduct patient screening for potential drug misuse or abuse before prescribing a drug listed on schedule II or III under section 202 of the Controlled Substances Act ( 21 U.S.C. 812 ), according to standards established by the applicable State licensing body. 5. FDA review of naloxone The Secretary, acting through the Commissioner of Food and Drugs, shall conduct a review of naloxone to consider whether naloxone should cease to be subject to section 503(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353(b) ) and be available as an over-the-counter drug, in order to increase access to such drug. 6. Prescription opiate disposal The Secretary shall convene or coordinate with an existing entity an interagency working group— (1) to encourage States and local governments to increase opportunities for